Cenra Inc. (TPE:3716)
33.75
-0.20 (-0.59%)
At close: Jan 20, 2026
Cenra Revenue
Cenra had revenue of 2.06B TWD in the quarter ending September 30, 2025, a decrease of -4.54%. This brings the company's revenue in the last twelve months to 8.68B, down -2.82% year-over-year. In the year 2024, Cenra had annual revenue of 8.92B with 4.01% growth.
Revenue (ttm)
8.68B
Revenue Growth
-2.82%
P/S Ratio
0.57
Revenue / Employee
16.02M
Employees
542
Market Cap
4.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.92B | 344.17M | 4.01% |
| Dec 31, 2023 | 8.57B | 118.21M | 1.40% |
| Dec 31, 2022 | 8.46B | 507.51M | 6.38% |
| Dec 31, 2021 | 7.95B | -232.06M | -2.84% |
| Dec 31, 2020 | 8.18B | 211.36M | 2.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Panion & Bf Biotech | 2.04B |
| Medigen Biotechnology | 1.59B |
| BIONET | 1.22B |
| BioGend Therapeutics | 212.43M |
| HCmed Innovations | 122.94M |
| Caliway Biopharmaceuticals | 34.99M |